Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia

NCT07555743 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Insomnia
Major Depressive Disorder

Interventions

DRUG: Daridorexant 50 mg
DRUG: Placebo

Sponsor

Institut d'Investigació Biomèdica de Bellvitge

Collaborators

[object Object]
[object Object]